Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DAUNORUBICIN vs DEFERIPRONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DAUNORUBICIN vs DEFERIPRONE: Safety Overview

Metric DAUNORUBICIN DEFERIPRONE
Total FAERS Reports 9,852 2,487
Deaths Reported 2,263 287
Death Rate 23.0% 11.5%
Hospitalizations 4,248 923
Average Patient Age 28.7 yrs 41.7 yrs
% Female Patients 46.4% 57.4%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 20, 2018
Manufacturer Hikma Pharmaceuticals USA Inc. Chiesi USA, Inc.
Route INTRAVENOUS ORAL
Marketing Status Discontinued Prescription